Sep. 23 at 10:39 PM
$PTN - PALATIN TECHNOLOGIES INC - 10K - Updated Risk Factors
PTN’s 2025 risk factors spotlight ongoing going concern doubts, sharp cash decline, continued heavy losses, and uncertain profitability. Vyleesi’s sale brings delayed milestone hopes, while new Boehringer Ingelheim deals add revenue potential but with termination risks. Expanded disclosures stress regulatory, clinical, manufacturing, and commercialization hurdles, intense competition, reliance on third parties, and major dilution and delisting threats. #Biotechnology #PartnershipRisk #FinancialDistress #RegulatoryRisk #Pharmaceuticals
🟢 Added 🟠 Removed
https://d-risk.ai/PTN/10-K/2025-09-23